Safety of trastuzumab (Herceptin) during pregnancy: two case reports
- PMID: 20062589
- PMCID: PMC2803989
- DOI: 10.1186/1757-1626-2-9329
Safety of trastuzumab (Herceptin) during pregnancy: two case reports
Abstract
We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).
References
-
- Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica. 2006;91:1426–7. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5. - PubMed
-
- Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinksy MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–8. doi: 10.1016/j.cgh.2006.07.018. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5. - DOI - PubMed
-
- Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstetrics and Gynecology. 2005;105(3):642–3. - PubMed
LinkOut - more resources
Full Text Sources
